Moderna Stock News

With more to their businesses than COVID-19 revenue, these two companies have huge market opportunities ahead.

Vaxart is winning in two crucial areas.

Florida took its latest contradictory stand against federal efforts to manage the coronavirus pandemic on Monday, when the state's surgeon general, Joseph Ladapo, said that the state will formally rec

The company has hit several roadblocks along the coronavirus vaccine path.

Moderna made the announcement on Monday, which will open up COVID-19 vaccine availability to at least 92 low- to middle-income countries.

Moderna made the announcement on Monday, which will open up COVID-19 vaccine availability to at least 92 low- to middle-income countries.

Israeli officials were saying on Tuesday that ceasefire talks between Russia and Ukraine had reached a “critical juncture,” according to a report on Axios. With Prime Minister Naftali Bennett acting… Read more » The post Report: Russia-Ukraine Negotiations at Critical Juncture appeared first on Hamodia . In related news: Russia: Plane’s Safety ‘Threatened’ Over Syria South Korean Leader Says She’ll Resign After Lawmakers Act Paris Orly Airport Terrorist Wanted to Kill, Die for Islam Suicide Attackers Target Headquarters of Libya’s Electoral Commission Moderna Says Preparing for Launch of Coronavirus Vaccine Candidate

The company is rowing back, announcing an agreement on Monday to open a vaccine plant in Kenya that will make as many as 500 million doses annually

Moderna Inc says it would set up a manufacturing facility in Kenya, its first in Africa, to produce messenger RNA (mRNA) vaccines, including COVID-19 shots. Moderna said it expects to invest about $500 million in the Kenyan facility and supply as many as 500 million doses of mRNA vaccines to the continent each year. It […]

It was unclear precisely what the updated enforcement may look like, or what threats the company is responding to, in part because there is no manufacturing of Moderna vaccines other than by the company itself or its contractors Read more

Moderna Inc (NASDAQ: MRNA ) plans to develop and begin testing vaccines targeting 15 pathogens identified as the biggest public health risk by WHO and CEPI by 2025. The Company also said it would permanently wave its COVID-19 vaccine patents for shots intended for certain low- and middle-income countries. At its global … Full story available on Benzinga.com

Pharmaceutical giant Moderna has signed a memorandum of understanding (MOU) with Kenya’s government for its first mRNA vaccine manufacturing facility in Africa

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative Options For Infectious Diseas

Here''s a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative Options For Infectious Diseases Moderna, Inc. (NASDAQ: MRNA ) announced four initiatives to advance mRNA vaccines to prevent infectious diseases. They include its global public health portfolio to 15 vaccine programs and setting up the mRNA Access to provide its mRNA technology to researchers to explore new vaccines against emerging or neglected infectious diseases. Additionally, the company said it has resolved not to enforce its COVID patents in the Gavi COVAX AMC for 92 low- and middle-income countries. The company also said, with the assistance of the U.S. government, it has entered into a memorandum of understanding with Kenya to establish Kenya as the location for its mRNA manufacturing facility. Mallinckrodt Agrees To Pay $234M To Settle Lawsuit Alleging Underpayment Of Medicaid Drug Rebates Mallinckrodt plc (OTC: MNKKQ ) has agreed to pay $234 million to settle false claims act case brought by Whistleblower Law Collaborative regarding underpayment of Medicaid rebates for its drug Acthar.

PSCU || President Uhuru Kenyatta witnessed the signing of a memorandum of understanding between Kenya and Moderna to establish the first mRNA manufacturing facility in Africa. The state-of-the-art mRNA facility in Africa is expected to produce up to 500 million doses of vaccines each year. The Company anticipates investing up to $500 million in the […] The post Kenya To Set Up Africa’s First Vaccine Facility in Africa appeared first on Uzalendo News .